Nasdaq:SERA
SERA PROGNOSTICS, INC.
A technology firm providing predictive maintenance prognostics solutions for industrial clients with substantial cash reserves but facing persistent net losses.
Key Metrics
Investment Thesis
Bull Case
Investors might consider SERA as a turnaround play given its robust liquidity of $40M in cash and equivalents which provides a runway to pivot or acquire distressed assets. The company's specialized technology in prognostics addresses a growing global need for predictive maintenance in aging industrial infrastructure, potentially unlocking future value if operational efficiency improves. A strategic shift in business model could allow the firm to monetize its intellectual property more effectively against its heavy cash reserves.
Bear Case
The stock is unattractive due to persistent negative earnings and a revenue collapse from $0.3M in 2023 to just $0.1M in 2024, signaling a failing business model. With a gross profit of -$5k and operating expenses exceeding costs of revenue by nearly 460x, the company is burning through resources without generating sustainable income. The massive deficit in retained earnings and negative cash flow from operations indicate that without immediate operational restructuring, bankruptcy or dilution risks are imminent.
About SERA PROGNOSTICS, INC.
SERA PROGNOSTICS, INC. (NASDAQ: SERA) operates within the technology sector, specializing in prognostics and health management solutions that leverage data analytics to predict equipment failures. The company primarily serves industrial markets requiring advanced monitoring systems for critical infrastructure and heavy machinery. Despite recent financial volatility, the firm maintains a significant portfolio of marketable securities to support its operational activities.
Analysis
Management Discussion
Recent financial performance reveals a stark disconnect where operating costs have escalated to $36.7M while generating only $77k in revenue, resulting in an operating profit of -$36.6M. The company recorded a net loss of -$32.9M for the latest period, which is partially offset by strong interest income of $2.7M from its large cash and securities portfolio. Cash flow from operations turned negative at -$14.2M, contrasting with significant investing cash flows that likely stem from managing the company's substantial marketable security holdings.
Industry Overview
The prognostics and health management industry is experiencing rapid growth driven by the digitization of industrial assets and the critical need for predictive maintenance to prevent costly downtime. Companies in this space compete on the accuracy of their AI models and the depth of their domain knowledge across various machinery types. While market demand is high, barriers to entry are moderate, allowing established players with proprietary data advantages to maintain leadership while new entrants struggle to scale.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $268.0K | $306.0K | $77.0K |
| Cost of Revenue | $0 | $0 | $82.0K |
| Gross Profit | $268.0K | $306.0K | $-5.0K |
| Operating Expenses | $45.9M | $40.1M | $36.7M |
| Operating Income | $-45.7M | $-39.8M | $-36.6M |
| R&D | $14.2M | $15.2M | $14.7M |
| G&A | $16.8M | $16.3M | $16.1M |
| Marketing | $14.7M | $8.3M | $5.8M |
| Stock-Based Comp | $5.1M | $5.3M | $7.0M |
| D&A | $756.0K | $900.0K | $833.0K |
| Amortization | — | — | $19.0K |
| Other OpEx | $193.0K | $210.0K | $82.0K |
| Non-Operating Income | $0 | $0 | $0 |
| Interest Expense | — | — | $28.0K |
| Interest Income | $456.0K | $1.6M | $2.7M |
| Pre-Tax Income | $-45.7M | $-39.8M | $-36.6M |
| Income Tax | $0 | $0 | $0 |
| Continuing Ops | $-45.7M | $-39.8M | $-36.6M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-44.2M | $-36.2M | $-32.9M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-44.2M | $-36.2M | $-32.9M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $90.1M | $61.3M | $47.6M |
| Cash & Equivalents | $29.9M | $3.9M | $4.0M |
| Marketable Securities | $52.8M | $45.2M | $42.2M |
| Accounts Receivable | $113.0K | $160.0K | $34.0K |
| Prepaid Expenses | $1.3M | $795.0K | $1.3M |
| Other Current Assets | $6.0M | $11.3M | $19.0K |
| Long-Term Assets | $26.2M | $34.1M | $25.0M |
| Intangibles | — | — | $1.0M |
| Operating Leases | $1.7M | $1.2M | $613.0K |
| LT Securities | $21.3M | $30.8M | $22.0M |
| Other LT Assets | $3.2M | $2.1M | $1.4M |
| Total Assets | $116.3M | $95.4M | $72.6M |
| Current Liabilities | $15.5M | $24.4M | $24.8M |
| Accounts Payable | $1.5M | $1.0M | $2.0M |
| Current Leases | $519.0K | $578.0K | $644.0K |
| Deferred Revenue | $9.1M | $20.2M | $20.2M |
| Other Current Liab | $4.4M | $2.6M | $1.9M |
| Long-Term Liabilities | $1.8M | $840.0K | $2.0K |
| LT Operating Leases | $1.2M | $644.0K | $0 |
| Other LT Liab | $626.0K | $196.0K | $2.0K |
| Total Liabilities | $17.4M | $25.3M | $24.8M |
| Shareholders' Equity | $98.9M | $70.2M | $47.8M |
| Paid-In Capital | $310.6M | $317.1M | — |
| Retained Earnings | $-210.7M | $-246.9M | $-279.8M |
| AOCI | $-981.0K | $-15.0K | $60.0K |
| Total L&E | $116.3M | $95.4M | $72.6M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-44.2M | $-36.2M | $-32.9M |
| Non-Cash Adjustments | $1.5M | $-4.2M | $30.2M |
| Working Capital Changes | $8.1M | $13.3M | $-11.5M |
| Cash from Operations | $-34.6M | $-27.2M | $-14.2M |
| Capital Expenditures | $791.0K | $128.0K | $56.0K |
| Cash from Investing | $5.6M | $438.0K | $11.7M |
| Cash from Financing | $5.0K | $752.0K | $2.6M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-29.1M | $-26.0M | $163.0K |
| Beginning Cash | $58.9M | $29.9M | $3.9M |
| Ending Cash | $29.9M | $3.9M | $4.0M |
Frequently Asked Questions
How does SERA PROGNOSTICS, INC. make money?
The company's revenue streams are derived from licensing proprietary prognostic software, offering hardware-based monitoring sensors, and providing data analytics consulting services to industrial sectors. Given the low current revenue of $77k against a massive asset base of $42.2M in marketable securities, operations appear heavily reliant on strategic partnerships or non-core investments rather than traditional product sales.
What are the main risks for SERA?
The company faces severe financial distress with five consecutive years of net losses totaling over $150M cumulatively in the trend period, raising questions about long-term viability. Current revenue is negligible at $77k while operating expenses have surged to $36.7M, indicating a critical mismatch between cost structure and top-line generation. The retention of a massive retained earnings deficit of nearly $280M suggests accumulated burn that has not been addressed through profitable scaling. High interest expense relative to minimal current revenue further exacerbates solvency concerns.
What is SERA's competitive advantage?
SERA possesses deep domain expertise in prognostics algorithms that can significantly reduce downtime for high-value industrial equipment. The company holds a strong balance sheet with over $42M in marketable securities, providing ample liquidity to fund R&D and weather economic downturns. Their technology stack offers unique value by transforming raw sensor data into actionable predictive insights before failures occur.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.